Amundi Pioneer Asset Management Inc. purchased a new stake in Nu Skin Enterprises (NYSE:NUS) in the 4th quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The institutional investor purchased 2,810 shares of the company’s stock, valued at approximately $192,000.
Several other large investors have also recently modified their holdings of NUS. Cerebellum GP LLC purchased a new stake in shares of Nu Skin Enterprises in the 4th quarter valued at approximately $124,000. Zurcher Kantonalbank Zurich Cantonalbank lifted its position in shares of Nu Skin Enterprises by 38.6% in the 4th quarter. Zurcher Kantonalbank Zurich Cantonalbank now owns 3,082 shares of the company’s stock valued at $210,000 after acquiring an additional 858 shares in the last quarter. Dynamic Technology Lab Private Ltd purchased a new stake in shares of Nu Skin Enterprises in the 3rd quarter valued at approximately $219,000. Virtu Financial LLC purchased a new stake in shares of Nu Skin Enterprises in the 4th quarter valued at approximately $220,000. Finally, Ramsey Quantitative Systems purchased a new stake in shares of Nu Skin Enterprises in the 4th quarter valued at approximately $260,000. Institutional investors and hedge funds own 76.48% of the company’s stock.
In other news, General Counsel D Matthew Dorny sold 3,000 shares of the stock in a transaction on Monday, March 5th. The shares were sold at an average price of $72.69, for a total transaction of $218,070.00. Following the transaction, the general counsel now owns 44,399 shares in the company, valued at approximately $3,227,363.31. The sale was disclosed in a document filed with the SEC, which is accessible through the SEC website. Also, Chairman Steven Lund sold 13,978 shares of the stock in a transaction on Friday, January 19th. The stock was sold at an average price of $70.01, for a total transaction of $978,599.78. Following the transaction, the chairman now owns 4,769 shares in the company, valued at approximately $333,877.69. The disclosure for this sale can be found here. In the last 90 days, insiders have sold 55,593 shares of company stock worth $3,933,622. 5.20% of the stock is currently owned by company insiders.
NUS stock opened at $73.71 on Monday. Nu Skin Enterprises has a 12-month low of $52.88 and a 12-month high of $75.00. The company has a debt-to-equity ratio of 0.44, a current ratio of 1.74 and a quick ratio of 1.17. The company has a market capitalization of $3,888.20, a price-to-earnings ratio of 22.82, a P/E/G ratio of 2.05 and a beta of 1.43.
Nu Skin Enterprises (NYSE:NUS) last released its earnings results on Thursday, February 15th. The company reported $1.20 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $1.19 by $0.01. Nu Skin Enterprises had a net margin of 5.68% and a return on equity of 25.23%. The company had revenue of $666.20 million during the quarter, compared to the consensus estimate of $667.39 million. During the same quarter in the prior year, the firm earned $0.79 EPS. The company’s revenue was up 25.4% compared to the same quarter last year. research analysts expect that Nu Skin Enterprises will post 3.56 earnings per share for the current fiscal year.
The firm also recently declared a quarterly dividend, which was paid on Wednesday, March 14th. Stockholders of record on Monday, February 26th were paid a dividend of $0.365 per share. This is a positive change from Nu Skin Enterprises’s previous quarterly dividend of $0.36. The ex-dividend date of this dividend was Friday, February 23rd. This represents a $1.46 annualized dividend and a dividend yield of 1.98%. Nu Skin Enterprises’s dividend payout ratio is 45.20%.
COPYRIGHT VIOLATION WARNING: “2,810 Shares in Nu Skin Enterprises (NUS) Acquired by Amundi Pioneer Asset Management Inc.” was originally reported by WKRB News and is the sole property of of WKRB News. If you are accessing this story on another domain, it was illegally stolen and reposted in violation of United States and international trademark and copyright legislation. The original version of this story can be accessed at https://www.wkrb13.com/2018/04/02/2810-shares-in-nu-skin-enterprises-nus-acquired-by-amundi-pioneer-asset-management-inc.html.
About Nu Skin Enterprises
Nu Skin Enterprises, Inc develops and distributes anti-aging personal care products and nutritional supplements under the Nu Skin and Pharmanex category brands worldwide. It provides skin care systems and targeted treatment products, including ageLOC Me customized skin care systems, ageLOC Spa systems, and ageLOC LumiSpa skin treatment and cleansing devices; and Epoch products, as well as a range of other cosmetic, personal care, and hair care products.
Want to see what other hedge funds are holding NUS? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Nu Skin Enterprises (NYSE:NUS).
Receive News & Ratings for Nu Skin Enterprises Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Nu Skin Enterprises and related companies with MarketBeat.com's FREE daily email newsletter.